Inventor · disambiguated record
Dominique Boutriau
Also filed as: BOUTRIAU DOMINIQUE
13 granted patents·10 pending applications·122 citations·filing 2001–2019
93Inventor score
Files withGLAXOSMITHKLINE BIOLOGICALS SA9BIEMANS RALPH LEON5GLAXOSMITHKLINE BIOLOG SA5BOUTRIAU DOMINIQUE2
Top patents by PatentIndex Score
23 records- 0194US9486515B2Immunogenic compositionBIEMANS RALPH LEON·Filed 2006·Granted Nov 8, 2016·16 cites·7 claims
- 0294US8398983B2Immunogenic compositionBIEMANS RALPH LEON·Filed 2006·Granted Mar 19, 2013·17 cites·31 claims
- 0393US8431136B2Immunogenic compositionBIEMANS RALPH LEON·Filed 2006·Granted Apr 30, 2013·13 cites·23 claims
- 0492US9789179B2Immunogenic compositionBIEMANS RALPH LEON·Filed 2006·Granted Oct 17, 2017·11 cites·39 claims
- 0592US8883163B2Immunogenic compositionGLAXOSMITHKLINE BIOLOG SA·Filed 2013·Granted Nov 11, 2014·11 cites·18 claims
- 0691US10245317B2Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Apr 2, 2019·5 cites·11 claims
- 0791US9358279B2Immunogenic compositionGLAXOSMITHKLINE BIOLOG SA·Filed 2014·Granted Jun 7, 2016·8 cites·1 claims
- 0888US10166287B2Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Jan 1, 2019·3 cites·4 claims
- 0988US9931397B2Immunogenic compositionBIEMANS RALPH LEON·Filed 2006·Granted Apr 3, 2018·6 cites·17 claims
- 1087US10130694B2Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Nov 20, 2018·10 cites·19 claims
- 1185US9694064B2Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2013·Granted Jul 4, 2017·12 cites·19 claims
- 1283US9233151B2Vaccine compositionBOUTRIAU DOMINIQUE·Filed 2012·Granted Jan 12, 2016·10 cites·10 claims
- 1371US2020000911A1Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Application pending·0 cites
- 1469US11241495B2Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Feb 8, 2022·0 cites·5 claims
- 1561US2008069835A1Vaccine compositionGLAXOSMITHKLINE BIOLOG SA·Filed 2007·Application pending·0 cites
- 1658US2013266609A1Vaccine compositionGLAXOSMITHKLINE BIOLOG SA·Filed 2013·Application pending·0 cites
- 1757US2016129101A1Immunogenic composition for use in therapyGLAXOSMITHKLINE BIOLOG SA·Filed 2014·Application pending·0 cites
- 1854US2018104322A1Immunogenic composition for use in therapyGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Application pending·0 cites
- 1951US2004202668A1Vaccine compositionFiled 2002·Application pending·0 cites
- 2051US2017056490A1Immunogenic composition for use in therapyGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Application pending·0 cites
- 2150US2011212124A1Vaccine CompositionBOUTRIAU DOMINIQUE·Filed 2011·Application pending·0 cites
- 2244US2003180316A1Multivalent vaccine compositionFiled 2001·Application pending·0 cites
- 2341US2017281744A1Method of treatmentGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →